Tricare officials have announced that pharmacy costs will be increasing on Jan. 1, 2022, for military retirees and their families.
Co-payments will also be increasing for active-duty military families. The increases will range from $1 to $8.
The military pharmacy will still be the most affordable option for military beneficiaries to get their medications. At these pharmacies, you will not have a cost for covered brand-name and generic medications.
There are some groups of people that the increased co-pays will not affect. Here is a list of those who will not be impacted:
Active-duty service members themselves
Survivors of active-duty service members
Medically retired service members and their families
If you are wondering how much your co-pays may be going up, Military Times provides details:
Tricare Pharmacy Home Delivery (up to 90-day supply) *Generic formulary drugs co-pays increase from $10 to $12 *Brand-name formulary drugs increase from $29 to $34 *Non-formulary drugs increase from $60 to $68
Tricare retail network pharmacies (up to 30-day supply) *Generic formulary drugs increase from $13 to $14 *Brand-name formulary drugs increase from $33 to $38 *Non-formulary drugs increase from $60 to $68
Non-network pharmacies (up to 30-day supply) *Generic formulary drugs and brand-name formulary drugs will increase from $33 to $38, or the co-pay will be 20 percent of the total cost of the drug, whichever is greater, after meeting the annual deductible. *Non-formulary drugs will increase from $60 to $68, or the co-pay will be 20 percent of the total cost of the drug, whichever is greater, after meeting the annual deductible.
The new co-pays will take effect on Jan. 1, 2022.
If you are on a Tricare Prime plan, non-network prescription prices will stay the same.
One final thing to note, Walmart and Sam’s Club pharmacies will be leaving the Tricare network beginning on Dec. 15.
Tricare officials announced that CVS pharmacy will be coming back into the network, which hasn’t been an available option for the last 5 years.
Comments